This is a cache of https://www.uibk.ac.at/mpi/team/staff/solveigh-koeberle.html. It is a snapshot of the page at 2024-11-21T00:20:38.365+0100.
Solveigh-Koeberle – Universität Innsbruck

Dr. rer. nat. Dipl.-Pharm. Solveigh Koeberle

 

Solveigh-Koeberle

 

Michael Popp Institute

University of Innsbruck

Mitterweg 24, A-6020 Innsbruck, Austria

Phone:                 +43 512 507 – 57913
E-Mail:                  solveigh.koeberle@uibk.ac.at

 

Research

Ferroptosis-modulating natural products and their mode of action: Targeting Redox Signaling

 

 

X Messenger

Follow my latest news on X logo!

https://x.com/skoeberle9?t=UhaLNizEAgbMYz3J2f3xdw&s=09

 

 

curriculum vitae

Since April 2022
Principal investigator at the Michael Popp Institute, University of Innsbruck (Austria)

Since October 2022
Interim professor for the Chair in Medicinal Chemistry I, University of Regensburg (Germany)

2019-2022
Senior Lecturer at the Unit Pharmacognosy, University of Innsbruck (Austria)

2017-2019
Postdoc at the Department of Molecular Nutritional Science, University of Jena (Germany)

2011-2017
Postdoc at the Leibniz-Institute on Aging, Fritz Lipmann Institute e.V., Jena (Germany)

2009-2011
Postdoc at the Department of Cellular Neurobiology, The University of Tokyo (Japan)

2006-2009
Ph.D. in “Medicinal Chemistry” at the Department of Medicinal/Pharmaceutical Chemistry, University of Tübingen (Germany)

2000-2005
Education as pharmacist and diploma pharmacist at the University of Tübingen (Germany)

 

 Publications

  1. Koeberle SC*, Kipp AP, Stuppner H, Koeberle A* (2023) Ferroptosis-modulating small molecules for targeting drug-resistant cancer: Challenges and opportunities in manipulating redox signaling. Med Res Rev, DOI: 10.1002/med.21933. * Corresponding Author
  2. Wolfram T, Weidenbach, LM, Adolf J., Schwarz, M., Schädel P, Gollowitzer A, Werz O, Koeberle A, Kipp A and Koeberle SC* (2021) The trace element selenium is important for redox signaling in phorbol ester differentiated THP-1 macrophages. Int J Mol Sci. DOI: 3390/ijms222011060. * Corresponding Author
  3. Koeberle SC, Gollowitzer A, Laoukili J, Kranenburg O, Werz O, Koeberle A and Kipp AP (2020) Distinct and overlapping functions of glutathione peroxidases 1 and 2 in limiting NF-κB-driven inflammation through redox-active mechanisms. Redox Biol. DOI: 10.1016/j.redox.2019.101388.
  4. Koeberle SC, Kipp AP (2018). Selenium and inflammatory mediators. In: ‘Selenium’, Bernhard Michalke (Ed.) Molecular and Integrative Toxicology. DOI: 10.1007/978-3-319-95390-8_7. INVITED REVIEW/BOOK CHAPTER
  5. Bertz, M, Kühn, K, Koeberle, SC, Müller, MF, Hoelzer, D, Thies, K, Deubel, S, Thierbach, R, Kipp, AP (2018) Selenoprotein H controls cell cycle progression and proliferation of human colorectal cancer cells. Free Radic Biol Med. DOI: 10.1016/j.freeradbiomed.2018.01.010.
  6. Koeberle SC, Shinji T, Kuriu, T, Iwasaki H, Koeberle A, Schulz A, Helbing D, Yamagata Y, Morrison H, Okabe S (2017) Developmental stage-dependent regulation of spine formation by calcium calmodulin dependent protein kinase IIα and Rap1. Sci Rep. DOI: 10.1038/s41598-017-13728-y.
  7. Pein H, Koeberle SC*, Voelkel M, Schneider F, Rossi A, Loeser K, Sautebin L, Morrison H, Werz O, Koeberle A (2017) Vitamin A regulates Akt signaling through the phospholipid fatty acid composition. FASEB J (IF: 5.5). *shared first authorship. DOI: 10.1096/fj.201700078R.
  8. Koeberle A, Pergola C, Shindou H, Koeberle SC, Shimizu T, Laufer SA, Werz O (2015) Role of p38 mitogen-activated protein kinase in linking stearoyl-CoA desaturase-1 activity with ER homeostasis. FASEB J, 29, 2439-2449. DOI: 1096/fj.14-268474.
  9. Koeberle A, Shindou H, Koeberle SC, Laufer SA, Shimizu T, Werz O (2013) Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding. PNAS, 110 (7), 2546-2551 (IF: 10.7)
  10. Fischer S, Wentsch HK, Mayer-Wrangowski SC, Zimmermann M, Bauer SM, Storch K, Niess R, Koeberle SC, Grütter C, Boeckler FM, Rauh D, Laufer SA (2013) Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activity. J Med Chem, 56 (1), 241-253 (IF: 5.5).
  11. Koeberle SC, Fischer S, Schollmeyer D, Schattel V, Grütter C, Rauh D, Laufer SA (2012) Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinase. J Med Chem, 55 (12), 5868-5877 (IF: 5.4).
  12. Koeberle SC, Romir J, Fischer S, Koeberle A, Schattel V, Albrecht W, Grütter C, Werz O, Rauh D, Stehle T, Laufer SA (2011) Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor. Nat Chem Biol, 8, 141-3 (IF: 16.1).
  13. Fischer S, Koeberle SC, Laufer SA (2011) p38α mitogen-activated protein kinase inhibitors, a patent review (2005-2011). Expert Opin Ther Pat, 21, 1843-66 (IF: 2.1).
  14. Karcher SC and Laufer, SA (2009) Successful structure-based design of recent p38 MAP kinase inhibitors. Curr Top Med Chem, 9, 655-676 (IF: 4.3).
  15. Karcher SC and Laufer SA (2009) Aza-analogue dibenzepinone scaffolds as p38 MAP kinase inhibitors: Design, synthesis and biological data of inhibitors with improved physico¬chemical properties. J Med Chem, 52, 1778-1782 (IF: 5.2).
  16. Laufer SA, Ahrens GM, Karcher SC, Hering JS, Niess R. (2006) Design, synthesis, and biological evaluation of phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones and dibenzo[a,d]cycloheptan-5-ones: Novel p38 MAP kinase inhibitors. J Med Chem, 49 (26), 7912-7915 (IF: 5.1)

 

Awards, fellowships and fundings

2022 ICTEM Travel Award, International Conference of Trace Elements and Minerals 2022 in Aachen (Germany)
2019-2021
 Grant of the Friedrich-Schiller University of Jena (Germany)
2016-2017 Fellowship of the Leibniz Institute on Aging Jena (Germany)
2014-2015 Fellowship of the Leibniz Institute on Aging Jena (Germany)
2009-2011 Fellowship of the „Deutsche Pharmazeutische Gesellschaft“(DPhG) / Pharmaceutical  Society of Japan (PSJ) and of the Takeda Science Foundation for a 2-year research period at The University of Tokyo (Japan)
2005 Participation at the “55th meeting of Nobel laureates in Medicine, Chemistry, and Physics in Lindau” (Germany)

        

Memberships

Since 2004  Member of the German Pharmaceutical Society (DPhG)
Since 2009  Member of the Takeda Science Foundation
2010    Member of the “Japanese Society of Neuroscience”
Since 2018 Member of the Society of Minerals and Trace Elements (GMS)
Since 2020 Member of the Herbal Medicinal Products Platform Austria (HMPPA)
Since 2024 Member of the Society of Medicinal Plant and Natural Product Research


Oral Presentations

2023 Oral presentation at the Seminar "Current Discoveries in Biomedical Research" (Innsbruck, Austria) 2023
2023 Oral presentation at the Annual DPhG Annual Meeting 2023 (Tübingen, Germany)
2023 Oral presentation at the EMBO Workshop Ferroptosis: When metabolism meets cell death (Seeon- Seebruck, Germany)
2022 Oral presentation at the CMBI (Center for Molecular Biosciences Innsbruck) Meeting 2022 (Igls, Austria)
2022 INVITED TALK, Mini-Symposium: Michael Popp Institute, University of Innsbruck - German Cancer Research Center, Heidelberg. Cell death: metabolism, bioactive lipids and therapeutic strategies (VIRTUAL)
2022 INVITED TALK at the ICTEM (International Conference of Trace Elements and Minerals 2022 (Aachen, Germany)
2021 INVITED TALK at the HMPPA Symposium Milk Thistle: Phytochemical, pharmacological and clinical evidence (VIRTUAL)  
2021 Highlight Talk at the Annual DPhG Annual Meeting 2021 (VIRTUAL)
2021 Presentation at the HMPPA Symposium “Next Generation in Pharmacognosy”  2021 (Krems, Austria)
2021 Highlight Talk at the EUFEPS (Meeting of the European Federation of Pharmaceutical Science) 2021 (VIRTUAL)
2021 Highlight Talk at the Meeting Frontiers in Medicinal Chemistry 2021 (VIRTUAL)
2021 Oral presentation at the 58. Scientific Congress of the DGE (German Society of Nutrition) 2020 (VIRTUAL)
2020 Oral presentation at the Seminar “Current research results in Pharmacy“ (Innsbruck, Austria) 2021 (VIRTUAL)
2012 Oral presentation for the Evaluation of the Leibniz Institute on Aging Jena (Jena, Germany)
2011
 Oral presentation at the Leibniz Institute on Aging Jena (Jena, Germany)
2010
 Oral presentation at the Joint Workshop, The University of Tokyo (Tokyo, Japan)
2009
 Oral presentation at the University of Tübingen (Tübingen, Germany)
2005 Oral presentation at the University of Tübingen (Tübingen, Germany)

         

Peer review activities

  • Nature (IF 64.8)
  • Cancer Communications (IF 16.8)
  • Theranostics (IF 12.4)
  • British Journal of Pharmacology (IF 8.7)
  • International Journal of Molecular Science (IF 6.2)
  • Food and Chemical Toxicology (IF 5.6)
  • BioMed Research International (IF 3.4)

 

Public Relation Work

2021
 Contribution to the reorganization of the sector “Medicinal Plants” and “Agricultural Plants” of the Botanical Garden in Innsbruck

                     

 

 

Nach oben scrollen